tiprankstipranks
United Therapeutics (DE:UTH)
FRANKFURT:UTH

United Therapeutics (UTH) Financial Statements

2 Followers

United Therapeutics Financial Overview

United Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; United Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is €5.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 614.70M$ 609.40M$ 596.50M$ 506.90M$ 491.50M
Gross Profit$ 543.70M$ 539.30M$ 532.40M$ 454.60M$ 29.60M
EBIT$ 310.50M$ 367.40M$ 350.00M$ 276.50M$ 168.60M
EBITDA$ 324.20M$ 380.70M$ 362.90M$ 289.80M-
Net Income Common Stockholders$ 217.10M$ 267.60M$ 259.20M$ 240.90M$ 132.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.99B$ 2.88B$ 2.68B$ 2.86B$ 2.84B
Total Assets$ 7.17B$ 7.02B$ 6.68B$ 6.35B$ 6.04B
Total Debt$ 700.00M$ 800.00M$ 800.00M$ 800.00M$ 800.00M
Net Debt$ -2.29B$ -2.08B$ -1.88B$ -2.06B$ -2.04B
Total Liabilities$ 1.18B$ 1.31B$ 1.27B$ 1.22B$ 6.04B
Stockholders Equity$ 5.98B$ 5.71B$ 5.41B$ 5.12B$ 4.80B
Cash Flow-
Free Cash Flow$ 72.00M$ 280.50M$ 61.60M$ 333.50M$ 88.70M
Operating Cash Flow$ 150.70M$ 346.20M$ 106.30M$ 374.80M$ 128.20M
Investing Cash Flow$ 42.10M$ -313.40M$ -227.20M$ -221.10M$ -189.30M
Financing Cash Flow$ -92.80M$ 7.60M$ 24.70M$ 48.60M$ 55.50M
Currency in USD

United Therapeutics Earnings and Revenue History

United Therapeutics Debt to Assets

United Therapeutics Cash Flow

United Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis